Vnitr Lek 2023, 69(6):E4-E11 | DOI: 10.36290/vnl.2023.079

Endoscopic and surgical therapy for obesity

Jan Král1, 4, Filip Doleček3, Kateřina Waloszková1, Jana Selucká1, Evžen Machytka1, Julius Špičák1, Marek Bužga2
1 Oddělení pro metabolickou endoskopii, Institut klinické a experimentální medicíny, Praha
2 Oddělení fyziologie a patofyziologie, Lékařská fakulta, Ostravská univerzita, Ostrava
3 Oddělení chirurgie, Lékařská fakulta, Ostravská univerzita, Ostrava
4 2. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Motol, Praha

Obesity is a serious disease whose incidence continues to rise worldwide. Obesity-associated diseases lead to reduced quality of life and increased mortality (high blood pressure, dyslipidemia, type 2 diabetes mellitus, etc.). The treatment of obesity is a multidisciplinary and complex process that requires consistent patient cooperation. Lifestyle change is the cornerstone of successful obesity treatment. Pharmacological therapy has experienced a renaissance in recent years and its role, both in monotherapy and in combination with other methods, will gradually become more important. Endoscopic therapy is a rapidly evolving subfield of digestive endoscopy that offers a variety of new methods to reduce, for example, gastric volume or small bowel bypass. The methods are both effective and have a low risk of complications. Surgical therapy, on the other hand, is highly effective, but is burdened with a higher incidence of complications. Bariatric surgery is primarily for patients with advanced obesity with comorbidities. The aim of this publication is to give a comprehensive review of the current endoscopic and surgical methods in the treatment of obesity.

Keywords: obesity, endoscopy, bariatric surgery, weight loss.

Accepted: October 5, 2023; Published: October 10, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Král J, Doleček F, Waloszková K, Selucká J, Machytka E, Špičák J, Bužga M. Endoscopic and surgical therapy for obesity. Vnitr Lek. 2023;69(6):E4-11. doi: 10.36290/vnl.2023.079.
Download citation

References

  1. Overweight and obesity - BMI statistics, (
  2. Adult Obesity Facts, 2020.
  3. Organization, W. H. Obesity and overweight, 2020.
  4. Purkyně, Čl s JE Obezita v České republice, 2013.
  5. ústav, S. z. Studie Zdraví dětí 2016, 2016.
  6. World Health, O. Obesity and overweight. 2021.
  7. Yumuk V, et al. European Guidelines for Obesity Management in Adults. Obes Facts 2015; 8:402-424. Available from: https://doi.org:10.1159/000442721 Go to original source... Go to PubMed...
  8. Bluher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol 2019;15:288-298. Available from: https://doi.org:10.1038/s41574-019-0176-8 Go to original source... Go to PubMed...
  9. Heymsfield SB, Wadden TA. Mechanisms, Pathophysiology, and Management of Obesity. New England Journal of Medicine 2017;376:254-266. Available from: https://doi.org:10.1056/NEJMra1514009 Go to original source... Go to PubMed...
  10. Cusi K. Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications. Gastroenterology 2012;142:711-U109. Available from: https://doi.org:10.1053/j.gastro.2012.02.003 Go to original source... Go to PubMed...
  11. Yanovski SZ, Yanovski JA. Obesity. The New England journal of medicine 2002;346:591-602. Available from: https://doi.org:10.1056/NEJMra012586 Go to original source... Go to PubMed...
  12. Eldar S, Heneghan HM, Brethauer SA, et al. Bariatric surgery for treatment of obesity. International journal of obesity 2011;35:S16-S21. Available from: https://doi.org:10.1038/ijo.2011.142 Go to original source... Go to PubMed...
  13. Smith BR, Schauer P, Nguyen NT. Surgical Approaches to the Treatment of Obesity: Bariatric Surgery. Medical Clinics of North America 2011;95:1009-+. Available from: https://doi.org:10.1016/j.mcna.2011.06.010 Go to original source... Go to PubMed...
  14. Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England journal of medicine 2002;346:393-403. Available from: https://doi.org:10.1056/NEJMoa012512 Go to original source... Go to PubMed...
  15. Jung SH, et al. Comparative efficacy of bariatric endoscopic procedures in the treatment of morbid obesity: a systematic review and network meta-analysis. Endoscopy 2020;52:940-954. Available from: https://doi.org:10.1055/a-1149-1862 Go to original source... Go to PubMed...
  16. Eisenberg D, et al. American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery. Obesity surgery 2022;33:3-14. Available from: https://doi.org:10.1007/s11695-022-06332-1 Go to original source... Go to PubMed...
  17. Neylan CJ, Dempsey DT, Tewksbury CM, et al. Endoscopic treatments of obesity: a comprehensive review. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2016;12:1108-1115. Available from: https://doi.org:10.1016/j.soard.2016.02.006 Go to original source... Go to PubMed...
  18. Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic Bariatric and Metabolic Therapies: New and Emerging Technologies. Gastroenterology 2017;152:1791-1801. Available from: https://doi.org:10.1053/j.gastro.2017.01.044 Go to original source... Go to PubMed...
  19. Tate CM, Geliebter A. Intragastric Balloon Treatment for Obesity: Review of Recent Studies. Adv Ther 2017;34:1859-1875. Available from: https://doi.org:10.1007/s12325-017-0562-3 Go to original source... Go to PubMed...
  20. Vargas EJ, et al. Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-World Population. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2018;16:1073-1080 e1071. Available from: https://doi.org:10.1016/j.cgh.2018.01.046 Go to original source... Go to PubMed...
  21. Abu Dayyeh BK, et al. Endoscopic bariatric therapies. Gastrointestinal endoscopy 2015;81:1073-1086. Available from: https://doi.org:10.1016/j.gie.2015.02.023 Go to original source... Go to PubMed...
  22. Herve J, et al. What becomes of patients one year after the intragastric balloon has been removed? Obesity surgery 2005;15:864-870. Available from: https://doi.org:10.1381/0960892054222894 Go to original source... Go to PubMed...
  23. Marinos G, Eliades C, Muthusamy VR, et al. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3-and 6-month study. Surgery for Obesity and Related Diseases 2014;10:929-934. Available from: https://doi.org:10.1016/j.soard.2014.03.005 Go to original source... Go to PubMed...
  24. Sauer N, et al. A new endoscopically implantable device (SatiSphere) for treatment of obesity-efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels. Obesity surgery 2013;23:1727-1733. Available from: https://doi.org:10.1007/s11695-013-1005-0 Go to original source... Go to PubMed...
  25. Barrichello S, et al. Endoscopic sleeve gastroplasty in the management of overweight and obesity: an international multicenter study. Gastrointestinal endoscopy 2019;90:770-780. Available from: https://doi.org:10.1016/j.gie.2019.06.013 Go to original source... Go to PubMed...
  26. Huberty V, et al. Endoscopic sutured gastroplasty in addition to lifestyle modification: short-term efficacy in a controlled randomised trial. Gut 2020. Available from: https://doi.org:10.1136/gutjnl-2020-322026 Go to original source...
  27. Lopez-Nava G, Bautista-Castano I, Jimenez A, et al. The Primary Obesity Surgery Endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2015;11:861-865. Available from: https://doi.org:10.1016/j.soard.2014.09.026 Go to original source... Go to PubMed...
  28. Sullivan S, et al. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trial. Obesity (Silver Spring) 2017;25:294-301. Available from: https://doi.org:10.1002/oby.21702 Go to original source... Go to PubMed...
  29. Kumar N. Endoscopic therapy for weight loss: Gastroplasty, duodenal sleeves, intragastric balloons, and aspiration. World journal of gastrointestinal endoscopy 2015;7:847-859. Available from: https://doi.org:10.4253/wjge.v7.i9.847 Go to original source... Go to PubMed...
  30. Deviere J, et al. Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study. Surgical endoscopy 2008;22:589-598. Available from: https://doi.org:10.1007/s00464-007-9662-5 Go to original source... Go to PubMed...
  31. Moreno C, et al. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy 2008;40,406-413. Available from: https://doi.org:10.1055/s-2007-995748 Go to original source... Go to PubMed...
  32. Koehestanie P, et al. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Annals of surgery 2014;260:984-992. Available from: https://doi.org:10.1097/SLA.0000000000000794 Go to original source... Go to PubMed...
  33. Forner PM, Ramacciotti T, Farey JE, et al. Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrierA (R)): Outcomes in 114 Patients. Obesity surgery 2017;27:3306-3313. Available from: https://doi.org:10.1007/s11695-017-2939-4 Go to original source... Go to PubMed...
  34. Sandler BJ, et al. One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity. Surgical endoscopy 2015;29:3298-3303. Available from: https://doi.org:10.1007/s00464-015-4081-5 Go to original source... Go to PubMed...
  35. Norén E, Forssell H. Aspiration therapy for obesity; a safe and effective treatment. BMC Obes 2016;3:56. Available from: https://doi.org:10.1186/s40608-016-0134-0 Go to original source... Go to PubMed...
  36. Thompson CC, et al. Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2019;15:1348-1354. Available from: https://doi.org:10.1016/j.soard.2019.04.026
  37. Machytka E, et al. Partial jejunal diversion using an incisionless magnetic anastomosis system: 1-year interim results in patients with obesity and diabetes. Gastrointestinal endoscopy 2017;86:904-912. Available from: https://doi.org:10.1016/j.gie.2017.07.009 Go to original source... Go to PubMed...
  38. Bang CS, et al. Effect of intragastric injection of botulinum toxin A for the treatment of obesity: a meta-analysis and meta-regression. Gastrointestinal endoscopy 2015;81:1141-1149 e1141-1147. Available from: https://doi.org:10.1016/j.gie.2014.12.025 Go to original source... Go to PubMed...
  39. Arterburn DE, Telem DA, Kushner RF, et al. Benefits and Risks of Bariatric Surgery in Adults: A Review. JAMA : the journal of the American Medical Association 2020;324:879-887. Available from: https://doi.org:10.1001/jama.2020.12567 Go to original source... Go to PubMed...
  40. O'Brien PE, et al. Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding. Obesity surgery 2019;29:3-14. Available from: https://doi.org:10.1007/s11695-018-3525-0 Go to original source... Go to PubMed...
  41. Almino Ramos LK, Wendy Brown, Richard Welbourn, et al. 5th IFSO global registry report. 2019.
  42. Gagner M, Hutchinson C, Rosenthal R. Fifth International Consensus Conference: current status of sleeve gastrectomy. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2016;12:750-756. Available from: https://doi.org:10.1016/j.soard.2016.01.022 Go to original source... Go to PubMed...
  43. Musella M, et al. Evaluation of reflux following sleeve gastrectomy and one anastomosis gastric bypass: 1-year results from a randomized open-label controlled trial. Surgical endoscopy 2021; 35, 6777-6785. Available from: https://doi.org:10.1007/s00464-020-08182-3 Go to original source... Go to PubMed...
  44. Sancho Moya C, et al. The Impact of Sleeve Gastrectomy on Gastroesophageal Reflux Disease in Patients with Morbid Obesity. Obesity surgery 2022;32:615-624. Available from: https://doi.org:10.1007/s11695-021-05808-w Go to original source... Go to PubMed...
  45. Gagner M, Deitel M, Erickson AL, et al. Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. Obesity surgery 2013;23:2013-2017. Available from: https://doi.org:10.1007/s11695-013-1040-x Go to original source... Go to PubMed...
  46. Lauti M, Kularatna M, Hill AG, et al. Weight Regain Following Sleeve Gastrectomy-a Systematic Review. Obesity surgery 2016;26:1326-1334. Available from:https://doi.org:10.1007/s11695-016-2152-x Go to original source... Go to PubMed...
  47. Abdelgawad M, et al. Long-Term Outcomes of Laparoscopic Gastric Plication for Treatment of Morbid Obesity: a Single-Center Experience. Obesity surgery 2022;32:3324-3331. Available from: https://doi.org:10.1007/s11695-022-06217-3 Go to original source... Go to PubMed...
  48. Khidir N, et al. Outcomes of Laparoscopic Gastric Greater Curvature Plication in Morbidly Obese Patients. J Obes 2017;2017:7989714. https://doi.org:10.1155/2017/7989714 Go to original source... Go to PubMed...
  49. Gudaityte R, Adamonis K, Maleckas A. Laparoscopic Gastric Greater Curvature Plication: Intermediate Results and Factors Associated with Failure. Obesity surgery 2018;28:4087-4094. Available from: https://doi.org:10.1007/s11695-018-3465-8 Go to original source... Go to PubMed...
  50. Alvarez R, Sandoval DA, Seeley RJ. A rodent model of partial intestinal diversion: a novel metabolic operation. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2020;16:270-281. Available from: https://doi.org:10.1016/j.soard.2019.10.026 Go to original source... Go to PubMed...
  51. Nakanishi H, et al. Impact on Mid-Term Health-Related Quality of Life after Duodenal Switch: a Systematic Review and Meta-Analysis. Obesity surgery 2023;33:769-779. Available from: https://doi.org:10.1007/s11695-022-06449-3 Go to original source... Go to PubMed...
  52. Scopinaro N, et al. Biliopancreatic diversion. World journal of surgery 1998;22:936-946. Available from: https://doi.org:10.1007/s002689900497 Go to original source... Go to PubMed...
  53. Scopinaro N, et al. Biliopancreatic diversion for obesity at eighteen years. Surgery 1996; 119, 261-268. Available from: https://doi.org:10.1016/s0039-6060(96)80111-5 Go to original source... Go to PubMed...
  54. Bianchi A, Pagan-Pomar A, Jimenez-Segovia M, et al. Biliopancreatic Diversion in the Surgical Treatment of Morbid Obesity: Long-Term Results and Metabolic Consequences. Obesity surgery 2020;30:4234-4242. Available from: https://doi.org:10.1007/s11695-020-04777-w Go to original source... Go to PubMed...
  55. Lyo V, Schafer AL, Stewart L. Roux-en-Y gastric bypass is a safe and effective option that improves major Co-Morbidities associated with obesity in an older, veteran population. American journal of surgery 2019;218:684-688. Available from: https://doi.org:10.1016/j.amjsurg.2019.07.027 Go to original source... Go to PubMed...
  56. Hatoum IJ, Kaplan LM. Advantages of percent weight loss as a method of reporting weight loss after Roux-en-Y gastric bypass. Obesity (Silver Spring) 2013;21:1519-1525. Available from: https://doi.org:10.1002/oby.20186 Go to original source... Go to PubMed...
  57. Tremmel M, Gerdtham UG, Nilsson PM, et al. S. Economic Burden of Obesity: A Systematic Literature Review. Int J Environ Res Public Health 2017;14. Available from: https://doi.org:10.3390/ijerph14040435 Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.